OHCS (Optimus Healthcare Svcs) Tariff Resilience Score: 0/10 (As of Jul. 12, 2026)


What is Optimus Healthcare Svcs Tariff Resilience Score?

Optimus Healthcare Svcs has the Tariff Resilience Score of 0, which implies that the company might have .

Optimus Healthcare Svcs has Optimus Healthcare Svcs Inc primarily operates domestically, reducing its exposure to international tariffs. Its supply chain is less dependent on imports, and the healthcare sector often receives exemptions. Historical tariff impacts have been negligible.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Optimus Healthcare Svcs might have .

Optimus Healthcare Svcs  (OTCPK:OHCS) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Optimus Healthcare Svcs Tariff Resilience Score Related Terms

Optimus Healthcare Svcs Business Description

Address 1400 Old Country Road, Suite 306, Westbury, NY, USA, 11590
Optimus Healthcare Svcs Inc focuses on acquiring controlling interests in healthcare-related businesses. The company is dedicated to advancing access to clinical trial research and simplifying access to vaccines and pharmaceutical products. It currently operates through its portfolio companies, Clinical Research Alliance, Inc. (CRA), and Worker's Health Rx (d/b/a "Vitality Rx"). The vision is to grow by acquiring controlling interests in healthcare-related businesses with products and services that improve healthcare access and outcomes. Optimus aims to empower physicians and patients with information and tools for informed healthcare decisions.